Protara Therapeutics (TARA) Other financing activities (2013 - 2026)
Protara Therapeutics (TARA) posted quarterly Other financing activities of $1.9 million for Q1 2026, up 194100.0% year-over-year from N/an in Q1 2025, and up 9610.0% quarter-over-quarter from $20000.0 in Q4 2025.
Powered by 
Analysis
Protara Therapeutics (TARA) Other financing activities (2013 - 2026) Analysis & Trends
Protara Therapeutics (TARA) has reported Other financing activities for 8 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities rose 194100.0% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $2.0 million (up 46.64% YoY), while the FY2025 annual figure was $21000.0, down 84.44% from the prior year.
- Other financing activities rose to $1.9 million in Q1 2026 per TARA's latest filing, from $20000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $1.9 million in Q1 2026 and bottomed at -$7000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Protara Therapeutics | 241.28 Mn | 241.28 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.94 Mn |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Jun 30, 2024 | -250,000.00 |
| Mar 31, 2024 | 385,000.00 |
| Dec 31, 2020 | 1.34 Mn |
| Dec 31, 2019 | 1.00 |
| Dec 31, 2017 | -1,000.00 |
| Jun 30, 2017 | 1,000.00 |
| Mar 31, 2017 | 108,000.00 |
| Dec 31, 2016 | 41,000.00 |
| Sep 30, 2016 | 17,000.00 |
| Jun 30, 2016 | 127,000.00 |
| Mar 31, 2016 | 12,000.00 |
| Dec 31, 2015 | 39,000.00 |
| Sep 30, 2015 | 42,000.00 |
| Dec 31, 2013 | 2,000.00 |